A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are ...
GLP-1 drugs like Ozempic and Wegovy may help reduce the risk of cardiovascular disease and prevent more than 34,000 heart ...
Whether positive or negative, your mood may feel different on GLP-1 medications. Researchers share why that might be and how ...
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
Italy: A recent analysis of the FDA Adverse Event Reporting System (FAERS) database has provided new insights into the safety ...
Karla Robinson, MD and Medical Editor at GoodRx discusses how GLP-1 receptor agonists work and their benefits.
Recently, GLP-1 receptor agonist medications have been prescribed more commonly, in part due to their ability to produce ...
A Cleveland Clinic study showed that in patients with type 2 diabetes, obesity, and chronic kidney disease, bariatric surgery was associated with a significant decrease in the progression of chronic ...
In the last couple of days at the European Association for the Study of Diabetes (EASD) 60th Annual Meeting 2024, the ...
GLP-1 receptor agonists like Ozempic and Wegovy have a lot of scientific data to support their use—and they can help people drop a lot of pounds. But is it possible to get the same results from ...